Skip to main content
. 2023 Jan 17;56:101820. doi: 10.1016/j.eclinm.2022.101820

Table 1.

Characteristics of study participants.

Variables Categories Participants, No. (%)
Total (N = 109) Intervention (n = 52) Control (n = 57)
Sex Women 37 (33.9) 15 (28.8) 22 (38.6)
Men 72 (66.1) 37 (71.2) 35 (61.4)
Marital status Never married 50 (45.9) 23 (44.2) 27 (47.4)
Married 50 (45.9) 28 (53.8) 22 (38.6)
Widowed 2 (1.8) 0 (0) 2 (3.5)
Divorced 7 (6.4) 1 (1.9) 6 (10.5)
Occupation status No job 22 (20.2) 9 (17.3) 13 (22.8)
Student 4 (3.7) 4 (7.7) 0 (0)
Farmer 1 (0.9) 0 (0) 1 (1.8)
Trader 10 (9.2) 5 (9.6) 5 (8.8)
Housewife 9 (8.3) 2 (3.8) 7 (12.3)
Government employee 10 (9.2) 5 (9.6) 5 (8.8)
Daily laborer 42 (38.5) 19 (36.5) 23 (40.4)
Other 11 (10.1) 8 (15.4) 3 (5.3)
Highest level of education No formal education 9 (8.3) 3 (5.8) 6 (10.5)
Primary 41 (37.6) 22 (42.3) 19 (33.3)
Secondary 28 (25.7) 12 (23.1) 16 (28.1)
Preparatory 11 (10.1) 5 (9.6) 6 (10.5)
University diploma 9 (8.3) 4 (7.7) 5 (8.8)
University diploma or above 11 (10.1) 6 (11.5) 5 (8.8)
Residential status Lives alone 13 (11.9) 5 (9.6) 8 (14.0)
Lives with family 83 (76.1) 42 (80.8) 41 (71.9)
Lives with friends 5 (4.6) 1 (1.9) 4 (7.0)
Homeless 6 (5.5) 3 (5.8) 3 (5.3)
Other 2 (1.8) 1 (1.9) 1 (1.8)
No. of cohabitants ≤3 63 (57.8) 32 (61.5) 31 (54.4)
4–6 37 (33.9) 16 (30.8) 21 (36.8)
7–9 7 (6.4) 2 (3.8) 5 (8.8)
≥10 2 (1.8) 2 (3.8) 0 (0)
No. of bedrooms 1 68 (62.4) 33 (63.5) 35 (61.4)
2 30 (27.5) 14 (26.9) 16 (28.1)
3 6 (5.5) 3 (5.8) 3 (5.3)
≥4 5 (4.6) 2 (3.8) 3 (5.3)
Household head Yes 61 (56.0) 31 (59.6) 30 (52.6)
No 48 (44.0) 21 (40.4) 27 (47.4)
Residency status Permanent 89 (81.7) 40 (76.9) 49 (85.9)
Temporary 20 (18.3) 12 (23.1) 8 (14.0)
Smoking, No./day Never 90 (82.6) 46 (88.5) 44 (77.2)
1–5 18 (16.5) 5 (9.6) 13 (22.8)
6–10 1 (0.9) 1 (1.9) 0 (0)
Khat (a stimulant) Never 87 (79.8) 43 (82.7) 44 (77.2)
1/week 10 (9.2) 3 (5.8) 7 (12.3)
≥2/week 8 (7.3) 4 (7.7) 4 (7.0)
1/month 4 (3.7) 2 (3.8) 2 (3.6)
Alcohol Never 67 (61.5) 35 (67.3) 32 (56.1)
>1/day 12 (11.0) 5 (9.6) 7 (12.3)
2-5/day 19 (17.4) 7 (13.5) 12 (21.1)
≥6/day 3 (2.8) 1 (1.9) 2 (3.5)
Rarely 8 (7.3) 4 (7.7) 4 (7.0)
HIVa Negative 93 (86.1) 44 (84.6) 49 (87.5)
Positive 15 (13.9) 8 (15.4) 7 (12.5)
On antiretroviral (If HIV positive) Yes 11 (73.3) 6 (75.0) 5 (71.4)
No 4 (26.7) 2 (25.0) 2 (28.6)
TB treatment New 98 (89.9) 46 (88.5) 52 (91.2)
Relapse 11 (10.1) 6 (11.5) 5 (8.8)
Place of diagnosis Study facility 75 (68.8) 33 (63.5) 42 (73.7)
Health center 3 (2.8) 1 (1.9) 2 (3.5)
Public hospital 10 (9.2) 8 (15.4) 2 (3.5)
Private clinic/hospital 20 (18.3) 9 (17.3) 11 (19.3)
Other 1 (0.9) 1 (1.9) 0 (0)
TB test methodology Microscopy 41 (37.6) 15 (28.8) 26 (45.6)
Xpert MTB/RIF 68 (62.4) 37 (71.2) 31 (54.4)
Microscopy result (If test with Microscopy)b 1-9 (Scanty) 1 (2.6) 0 (0) 1 (4.0)
1+ 10 (25.6) 5 (35.7) 5 (20.0)
2+ 12 (30.8) 7 (50.0) 5 (20.0)
3+ 16 (41.0) 2 (14.3) 14 (56.0)
Completed treatment (If ever treated for TB) Yes 11 (100) 6 (100) 5 (100)
No 0 (0) 0 (0) 0 (0)

TB: tuberculosis; ARV: antiretroviral; MTB/RIF: Mycobacterium tuberculosis/resistance to rifampicin.

a

1 missing value.

b

2 missing values.